Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson Dips On Q4 Earnings
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript
Good morning and welcome to Johnson & Johnson's fourth quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time.
Johnson & Johnson Q4 Profit Decreases, But Beats Estimates
Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The
Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing
Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the look-back and look-ahead on an earnings call,
Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.
Johnson & Johnson Q4 2024 Earnings Preview: Double-digit decline in profit expected
Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% from the prior year period.
53m
on MSN
GE Aerospace Q4 2024 earnings preview: All eyes on annual margin, delivery projections
GE Aerospace (NYSE:GE) is scheduled to announce Q4 earnings results on Thursday, January 23rd, before market opens. Citi ...
1h
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2024 Earnings Call Jan 22, 2025, 9:30 a.m. ET Trump says he 'most likely' will give TikTok ...
19h
Netflix (NFLX) Q4 2024 Earnings Call Transcript
Good afternoon, and welcome to the Netflix Q4 2024 earnings interview. I'm Spencer Wang, vice president of finance, IR, and ...
6h
Kingdom Capital Advisors Q4 2024 Investor Letter
Kingdom Capital Advisors (KCA Value Composite) returned 2.07% (net of fees) in 4Q, vs. 0.33% for Russell 2000 TR, 2.41% for S ...
JD Supra
32m
State and Federal PFAS Litigation – 2019 to Q4 2024
PFAS-related litigation continues to climb and to diversify as to claims and parties. See the attached graphics, updated ...
manilatimes
2h
HighCo: Q4 2024 Gross Profit
Q4 2024 gross profit 1 of €14.97 m, down 16%. FY 2024 gross profit 1 of €69.16 m, down 7%. Sustained annual growth in the ...
6h
Harding Loevner Global Equity Q4 2024 Report
The Global Equity composite fell 0.86% gross of fees in the fourth quarter, in line with the 0.89% decline of the MSCI ACWI ...
GM Authority
13h
U.S. Chevrolet Sales Grew Impressive 17 Percent During Q4 2024
Chevrolet sales grew 17 percent to 481,064 deliveries during Q4 2024 in the U.S. See Chevrolet USA sales figures, numbers, ...
JD Supra
1h
Life Sciences Law Update - Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy and Spain in Q4/ 2024
Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...
8h
The Optimist Fund Q4 2024 Quarterly Letter
Since inception, we have achieved approximately 15% annualized returns, net of fees, and are now approaching our 3- year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Netflix
United States
Earnings Call Transcript
Johnson & Johnson
Citigroup
Feedback